After upping its offering price, GlaxoSmithKline (GSK) finally bought out Human Genome Sciences (HGSI). The price was $3 Billion plus or minus for the hostile takeover turned agreeable with the sweetened pot. The takeover brings to mind the business of investing in buyout prospects. Human Genome Sciences was trading for just over $13.50 a share […]